home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Marrone Bio prepares to submit registration for next-generation crop protection product in North America - Company also looks to expand footprint in South America with regulatory submission of bionematicide seed treatment, MBI-206, in Brazil


Davis, California, USA
Sept. 09, 2021

Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, is on track to submit MBI-306, its next generation nematicide/insecticide, to regulatory authorities in the United States within the coming weeks. Destined for row and specialty crop markets globally, MBI-306 and its variants have been proven to perform as well as synthetic counterparts both in terms of efficacy and return on investment (ROI) to growers. The product is well positioned to be an important component of the $15.7 billion global insecticide market*, and is expected to generate peak potential incremental revenue for MBI in excess of $100 million.

“The regulatory submission of MBI-306 underscores our position as the differentiated leader to meet consumer and grower demand for sustainable agricultural solutions,” said Chief Executive Officer, Kevin Helash. “We have always believed biologicals have the potential, from both an efficacy and ROI standpoint, to compete directly with traditional products. MBI-306 is a result of our relentless R&D efforts to achieve that vision. I believe this product will be a true gamechanger for MBI,” Helash added.

MBI-306 and its variants are built on a proprietary microbe (Burkholderia rinojensis strain A396) that has been the foundation of the company’s Venerate® Bioinsecticide and Majestene® Bionematicide crop protection products. MBI-306 is proven to be efficacious against a broad spectrum of yield-robbing insects and nematodes, including corn rootworm larvae, often referred to as the billion-dollar pest in the United States.

In addition to the regulatory submission of MBI-306, MBI is in the final stages of preparing to submit MBI-206 — a popular bionematicide seed treatment used on more than 10 million acres in the United States — to Brazilian regulatory authorities. This will serve to further expand the company’s geographic footprint in one of the world’s largest corn and soybean markets with an estimated insecticide value of $2 billion in 2020.**

In addition to its impressive commercial performance, MBI-206 has also been evaluated for climate impact by a third-party, Boundless Impact Research and Analytics, and received an ‘outstanding’ score of 9.8 out of 10. Given the similarities in both products, MBI-306 is expected to receive an equally advantageous score and will be evaluated in the coming months.

Once approved, current plans are to produce both products at MBI’s dedicated manufacturing facility in Bangor, Michigan. The plant is on track to complete a more than $1 million capital investment in early 2022 where, once complete, it will shift to a 24-hour production cycle.

“MBI-206 and MBI-306 are two examples of how MBI continues to expand globally as the leader in sustainable plant health and protection tools for our grower customers. These products demonstrate our ability to take innovation from the lab and make it work in the field,” said Helash.

Commercial launch for both products is expected in 2023/2024.

Lake Street Capital 5th Annual Best Ideas Growth Conference

Helash will be addressing investors in one-on-one virtual meetings as part of the Lake Street Capital 5th Annual Best Ideas Growth Conference on Wednesday, September 15, 2021. Conference participation is by registration only, and interested participants should contact their Lake Street Capital representative at www.lakestreetcapitalmarkets.com.

Sources:

*, ** HIS Markit

 



More news from: Marrone Bio Innovations


Website: http://marronebioinnovations.com/

Published: September 10, 2021

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section


Copyright @ 1992-2024 SeedQuest - All rights reserved